Natural malaria infection elicits rare but potent neutralizing antibodies to the blood-stage antigen RH5
Combined approach of selective and accelerated cloning for microfluidic chip-based system increases clone specific productivity
DNAJB1-PRKACA fusion neoantigens elicit rare endogenous T cell responses that potentiate cell therapy for fibrolamellar carcinoma
Tumor-specific T cells in head and neck cancer have rescuable functionality and can be identified through single-cell co-culture
Rapid isolation of pan-neutralizing antibodies against Omicron variants from convalescent individuals infected with SARS-CoV-2
Current advances in experimental and computational approaches to enhance CAR T cell manufacturing protocols and improve clinical efficacy
Utilizing immunogenomic approaches to prioritize targetable neoantigens for personalized cancer immunotherapy
